Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy

類似資料

• ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
  著者:: Guberina, Maja, 等
  出版事項: (2020)
• SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy
  著者:: De-Colle, Chiara, 等
  出版事項: (2017)
• Heat shock protein 70 and tumor‐infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG)
  著者:: Stangl, Stefan, 等
  出版事項: (2017)
• A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling
  著者:: Leger, Stefan, 等
  出版事項: (2017)
• Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
  著者:: Niu, Minli, 等
  出版事項: (2021)